Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TSBX

Turnstone Biologics Corp

Sep 13 • 04:00PM ET

0.6592

Dollar change +0.0192
Percentage change 3.00	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.26	Insider Own	40.99%	Shs Outstand	23.10M	Perf Week	12.01%
Market Cap	15.25M	Forward P/E	-	EPS next Y	-2.48	Insider Trans	0.00%	Shs Float	13.65M	Perf Month	-69.76%
Income	-75.03M	PEG	-	EPS next Q	-0.89	Inst Own	32.73%	Short Float	3.49%	Perf Quarter	-76.46%
Sales	0.00M	P/S	-	EPS this Y	24.48%	Inst Trans	-	Short Ratio	1.77	Perf Half Y	-78.17%
Book/sh	2.58	P/B	0.26	EPS next Y	31.30%	ROA	-98.52%	Short Interest	0.48M	Perf Year	-86.55%
Cash/sh	2.70	P/C	0.24	EPS next 5Y	17.90%	ROE	-134.46%	52W Range	0.58 - 6.01	Perf YTD	-74.10%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-124.74%	52W High	-89.02%	Beta	2.19
Dividend TTM	-	Quick Ratio	4.38	Sales past 5Y	-50.65%	Gross Margin	85.50%	52W Low	13.66%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	4.38	EPS Y/Y TTM	-	Oper. Margin	0.00%	RSI (14)	22.52	Volatility	9.51% 10.68%
Employees	80	Debt/Eq	0.04	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	6.88
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	0.76%	Payout	-	Rel Volume	0.27	Prev Close	0.64
Sales Surprise	-	EPS Surprise	-9.52%	Sales Q/Q	-	Earnings	Aug 14 AMC	Avg Volume	268.81K	Price	0.66
SMA20	-7.54%	SMA50	-61.63%	SMA200	-73.85%	Trades		Volume	73,653	Change	3.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-16-23	Initiated	SVB Securities	Market Perform
Aug-15-23	Initiated	Piper Sandler	Overweight	$20
Aug-15-23	Initiated	BofA Securities	Buy	$18

Aug-14-24 09:54PM	TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024 (InvestorPlace) -61.93%
04:05PM	Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights (GlobeNewswire)
04:01PM	Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer (GlobeNewswire)
Aug-12-24 05:49PM	Turnstone Biologics Corp. (TSBX): This Penny Stock is a Strong Buy According to Analysts (Insider Monkey)
May-13-24 09:53PM	TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024 (InvestorPlace) -5.28%
05:01PM	Loading…
05:01PM	Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights (GlobeNewswire)
May-08-24 09:00AM	Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-16-24 09:00AM	Turnstone Biologics Appoints William Waddill to its Board of Directors (GlobeNewswire)
Mar-22-24 07:52AM	TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023 (InvestorPlace) -10.48%
Mar-21-24 05:06PM	Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights (GlobeNewswire) +8.44%
Feb-21-24 06:00AM	Turnstone Biologics to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.49%
Feb-20-24 05:00PM	Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq. (GlobeNewswire) -11.67%
Nov-27-23 06:00AM	Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-09-23 09:49PM	Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights (GlobeNewswire) -11.94%
Nov-03-23 06:00AM	Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
06:00AM	Loading…
Oct-30-23 06:00AM	Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber (GlobeNewswire) +24.12%
Sep-28-23 06:00AM	Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting (GlobeNewswire) +10.36%
Sep-01-23 05:57PM	Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +10.47% -11.83%
Aug-14-23 08:41PM	Steven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio Overview (GuruFocus.com)
Aug-04-23 06:30PM	Apogee Therapeutics, Turnstone Biologics, and More Stocks See Action From Activist Investors (Barrons.com) -5.67%
Jul-27-23 07:01PM	Steven Cohen Acquires Stake in Turnstone Biologics Corp (GuruFocus.com)
05:36PM	FMR LLC Acquires Significant Stake in Turnstone Biologics Corp (GuruFocus.com)
Jul-21-23 02:15AM	Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TSBX

Turnstone Biologics Corp

Upgrade your FINVIZ experience